Scoping review on impact of mosquito - borne diseases of man and animals and use of potential bacterial larvicidal agents to control mosquito vectors

Mosquito vector-borne disease which accounts for the transmission of many deadly diseases like dengue, zika, chikungunya, Rift Valley fever, malaria, West Nile fever, heartworm, lumpy skin disease is one of the major causes of mortality, morbidity, and economic loss to human and animal communities. Though there have been several interventions like insecticide-treated nets, spatial repellents, indoor pesticide sprays to control adult mosquitoes, it only remains effective for short time, possibly leading to faster replacement of the adults by immature only achieving lesser mosquito population reduction. Extensive use of synthetic insecticides leads to resistance, affects non-target organisms and cause ecological imbalance. While recognizing the limitations of the synthetic and adulticide-based mosquito control methods, alternatively, microbial larvicidal agents are more feasible, target-specific, environment-friendly, low application rates, and moderate costs when compared with other vector control measures. This review highlights the microbial larvicidal agents as a most promising tool in vector control management to prevent disease transmission and discusses the major mosquito-borne diseases affecting humans and other animals.